Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
{Taj Pharma Cancer Awareness Initiative} Genetic ‘fingerprints’ implicate gut bacterium in bowel cancer
The making of a living ovarian cancer biobank
WHO officially names new coronavirus disease Covid-19 The World Health Organization (WHO) has officially named the disease caused by the new coronavirus, initially identified in Wuhan, China, as Covid-19.
Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers {Taj Pharma}
What is melanoma? | Melanoma Stages | Melanoma Types | Melanoma Risk factors | Melanoma Symptoms | Melanoma Treatment | Prevention melanoma | Melanoma Diagnosis | Melanoma Outlook Melanoma is a type of skin cancer. It is not the most common, but it is the most serious, as it often spreads. When this happens, it […]
Immunotherapy comparable to chemo for some advanced stomach cancers [Taj Pharma Global Cancer initiative]
- Bacteria & Viruses
- Cancer
- Conferences & Events
- Corporate News
- COVID-19
- Current Events
- Disease Info
- Disease Trends
- Divisional News
- Drug Approvals
- Drug News
- Eating Habits
- Generic
- Global Agenda
- Health & Disease
- Health & Fitness
- Health Care
- Health Kiosk
- Health News
- Healthy Food
- Herbal Trends
- Industry News
- Infectious Disease
- Interactive Media
- Local News
- Media
- Medical News
- Mental Health
- Oncology News
- Press Release
#TajPharma #TajPharmaIndia #TajPharmaceuticalsIndia #TajPharmaHyderabad #TajPharmaMumbai #TajPharmaceuticalsProducts #TajPharmaOwner #TajPharmaCEO #TajPharmaceuticalsCEO #TajPharmaGujarat